Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Hearing loss in inherited peripheral neuropathies: Molecular diagnosis by NGS in a French series.

Lerat J, Magdelaine C, Roux AF, Darnaud L, Beauvais-Dzugan H, Naud S, Richard L, Derouault P, Ghorab K, Magy L, Vallat JM, Cintas P, Bieth E, Arne-Bes MC, Goizet C, Espil-Taris C, Journel H, Toutain A, Urtizberea JA, Boespflug-Tanguy O, Laffargue F, Corcia P, Pasquier L, Fradin M, Napuri S, Ciron J, Boulesteix JM, Sturtz F, Lia AS.

Mol Genet Genomic Med. 2019 Aug 8:e839. doi: 10.1002/mgg3.839. [Epub ahead of print]

2.

Residential exposure to ultra high frequency electromagnetic fields emitted by Global System for Mobile (GSM) antennas and amyotrophic lateral sclerosis incidence: A geo-epidemiological population-based study.

Luna J, Leleu JP, Preux PM, Corcia P, Couratier P, Marin B, Boumediene F; Fralim Consortium.

Environ Res. 2019 Jun 11;176:108525. doi: 10.1016/j.envres.2019.108525. [Epub ahead of print]

PMID:
31226626
3.

Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis.

Lanznaster D, Bejan-Angoulvant T, Patin F, Andres CR, Vourc'h P, Corcia P, Blasco H.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):199-206. doi: 10.1080/21678421.2019.1572192. Epub 2019 Apr 9.

PMID:
30961401
4.

Ferritin and LDL-cholesterol as biomarkers of fat-free mass loss in ALS.

Jésus P, Blasco H, Patin F, Bakkouche SE, Beltran S, Andrés CR, Vourc'h P, Maillot F, Corcia P.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):441-444. doi: 10.1080/21678421.2019.1597126. Epub 2019 Apr 3.

PMID:
30942089
5.

The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?

Hergesheimer RC, Chami AA, de Assis DR, Vourc'h P, Andres CR, Corcia P, Lanznaster D, Blasco H.

Brain. 2019 May 1;142(5):1176-1194. doi: 10.1093/brain/awz078.

6.

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Belmokhtar C, Lozeron P, Adams D, Franques J, Lacour A, Godet E, Bataille M, Dubourg O, Angibaud G, Delmont E, Bouhour F, Corcia P, Pouget J.

Neurol Ther. 2019 Jun;8(1):69-78. doi: 10.1007/s40120-019-0132-5. Epub 2019 Mar 22.

7.

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.

van den Berg LH, Sorenson E, Gronseth G, Macklin EA, Andrews J, Baloh RH, Benatar M, Berry JD, Chio A, Corcia P, Genge A, Gubitz AK, Lomen-Hoerth C, McDermott CJ, Pioro EP, Rosenfeld J, Silani V, Turner MR, Weber M, Brooks BR, Miller RG, Mitsumoto H; Airlie House ALS Clinical Trials Guidelines Group.

Neurology. 2019 Apr 2;92(14):e1610-e1623. doi: 10.1212/WNL.0000000000007242. Epub 2019 Mar 8.

8.

A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis.

Devos D, Moreau C, Kyheng M, Garçon G, Rolland AS, Blasco H, Gelé P, Timothée Lenglet T, Veyrat-Durebex C, Corcia P, Dutheil M, Bede P, Jeromin A, Oeckl P, Otto M, Meninger V, Danel-Brunaud V, Devedjian JC, Duce JA, Pradat PF.

Sci Rep. 2019 Feb 27;9(1):2918. doi: 10.1038/s41598-019-39739-5.

9.

The Relevancy of Data Regarding the Metabolism of Iron to Our Understanding of Deregulated Mechanisms in ALS; Hypotheses and Pitfalls.

Petillon C, Hergesheimer R, Puy H, Corcia P, Vourc'h P, Andres C, Karim Z, Blasco H.

Front Neurosci. 2019 Jan 15;12:1031. doi: 10.3389/fnins.2018.01031. eCollection 2018. Review.

10.

Metabo-lipidomics of Fibroblasts and Mitochondrial-Endoplasmic Reticulum Extracts from ALS Patients Shows Alterations in Purine, Pyrimidine, Energetic, and Phospholipid Metabolisms.

Veyrat-Durebex C, Bris C, Codron P, Bocca C, Chupin S, Corcia P, Vourc'h P, Hergesheimer R, Cassereau J, Funalot B, Andres CR, Lenaers G, Couratier P, Reynier P, Blasco H.

Mol Neurobiol. 2019 Aug;56(8):5780-5791. doi: 10.1007/s12035-019-1484-7. Epub 2019 Jan 24.

PMID:
30680691
11.

Typical bulbar ALS can be linked to GARS mutation.

Corcia P, Brulard C, Beltran S, Marouillat S, Bakkouche SE, Andres CR, Blasco H, Vourc'h P.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):275-277. doi: 10.1080/21678421.2018.1556699. Epub 2019 Jan 20.

PMID:
30661401
12.

Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS.

Lanznaster D, de Assis DR, Corcia P, Pradat PF, Blasco H.

Front Neurol. 2018 Dec 18;9:1126. doi: 10.3389/fneur.2018.01126. eCollection 2018. Review.

13.

Staging amyotrophic lateral sclerosis: A new focus on progression.

Corcia P, Beltran S, Lautrette G, Bakkouche S, Couratier P.

Rev Neurol (Paris). 2019 May;175(5):277-282. doi: 10.1016/j.neurol.2018.09.017. Epub 2018 Dec 31. Review.

PMID:
30606512
14.

In ALS, a mutation could be worth two steps.

Corcia P, Blasco H, Beltran S, Andres C, Vourc'h P, Couratier P.

Rev Neurol (Paris). 2018 Dec;174(10):669-670. doi: 10.1016/j.neurol.2018.11.001. No abstract available.

PMID:
30501924
15.

Development of permanent brain damage after subacute encephalopathy with seizures in alcoholics.

Duwicquet C, Biberon J, Corcia P, De Toffol B, Limousin N.

J Neurol Sci. 2019 Jan 15;396:12-17. doi: 10.1016/j.jns.2018.10.022. Epub 2018 Oct 25.

PMID:
30391820
16.

Co-occurrence of MS and ALS: a clue in favor of common pathophysiological findings?

Guennoc AM, Pallix-Guyot M, Le Page E, Le Port D, Daryabin M, Hergesheimer R, Beltran S, Tourbah A, Edan G, Corcia P.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):500-505. doi: 10.1080/21678421.2018.1476547. Epub 2018 Sep 3.

PMID:
30175630
17.

Pathology of Nerve Biopsy and Diagnostic Yield of PCR-Based Clonality Testing in Neurolymphomatosis.

Duchesne M, Roussellet O, Maisonobe T, Gachard N, Rizzo D, Armand M, Viala K, Richard L, Delage-Corre M, Jaccard A, Corcia P, Vallat JM, Magy L.

J Neuropathol Exp Neurol. 2018 Sep 1;77(9):769-781. doi: 10.1093/jnen/nly055.

PMID:
30011033
18.

A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression.

Blasco H, Patin F, Descat A, Garçon G, Corcia P, Gelé P, Lenglet T, Bede P, Meininger V, Devos D, Gossens JF, Pradat PF.

PLoS One. 2018 Jun 5;13(6):e0198116. doi: 10.1371/journal.pone.0198116. eCollection 2018.

19.

Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation.

Kreiter N, Pal A, Lojewski X, Corcia P, Naujock M, Reinhardt P, Sterneckert J, Petri S, Wegner F, Storch A, Hermann A.

Neurobiol Dis. 2018 Jul;115:167-181. doi: 10.1016/j.nbd.2018.03.010. Epub 2018 Apr 6.

PMID:
29630989
20.

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.

Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt JJFA, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, Körner S, Ringer TM, Rödiger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chiò A, Hardiman O, Moons KGM, Veldink JH, van den Berg LH.

Lancet Neurol. 2018 May;17(5):423-433. doi: 10.1016/S1474-4422(18)30089-9. Epub 2018 Mar 26.

21.

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A; ITALSGEN Consortium, Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L; Genomic Translation for ALS Care (GTAC) Consortium, Moreno CAM, Kamalakaran S, Goldstein DB; ALS Sequencing Consortium, Gitler AD, Harris T, Myers RM; NYGC ALS Consortium, Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC; Answer ALS Foundation, Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J; SLAGEN Consortium, Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C; French ALS Consortium, Corcia P, Laaksovirta H, Myllykangas L, Jansson L, Valori M, Ealing J, Hamdalla H, Rollinson S, Pickering-Brown S, Orrell RW, Sidle KC, Malaspina A, Hardy J, Singleton AB, Johnson JO, Arepalli S, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Al-Sarraj S, King A, Troakes C, Vance C, de Belleroche J, Baas F, Ten Asbroek ALMA, Muñoz-Blanco JL, Hernandez DG, Ding J, Gibbs JR, Scholz SW, Floeter MK, Campbell RH, Landi F, Bowser R, Pulst SM, Ravits JM, MacGowan DJL, Kirby J, Pioro EP, Pamphlett R, Broach J, Gerhard G, Dunckley TL, Brady CB, Kowall NW, Troncoso JC, Le Ber I, Mouzat K, Lumbroso S, Heiman-Patterson TD, Kamel F, Van Den Bosch L, Baloh RH, Strom TM, Meitinger T, Shatunov A, Van Eijk KR, de Carvalho M, Kooyman M, Middelkoop B, Moisse M, McLaughlin RL, Van Es MA, Weber M, Boylan KB, Van Blitterswijk M, Rademakers R, Morrison KE, Basak AN, Mora JS, Drory VE, Shaw PJ, Turner MR, Talbot K, Hardiman O, Williams KL, Fifita JA, Nicholson GA, Blair IP, Rouleau GA, Esteban-Pérez J, García-Redondo A, Al-Chalabi A; Project MinE ALS Sequencing Consortium, Rogaeva E, Zinman L, Ostrow LW, Maragakis NJ, Rothstein JD, Simmons Z, Cooper-Knock J, Brice A, Goutman SA, Feldman EL, Gibson SB, Taroni F, Ratti A, Gellera C, Van Damme P, Robberecht W, Fratta P, Sabatelli M, Lunetta C, Ludolph AC, Andersen PM, Weishaupt JH, Camu W, Trojanowski JQ, Van Deerlin VM, Brown RH Jr, van den Berg LH, Veldink JH, Harms MB, Glass JD, Stone DJ, Tienari P, Silani V, Chiò A, Shaw CE, Traynor BJ, Landers JE.

Neuron. 2018 Mar 21;97(6):1268-1283.e6. doi: 10.1016/j.neuron.2018.02.027.

22.

Phenotypic and genotypic studies of ALS cases in ALS-SMA families.

Corcia P, Vourc'h P, Blasco H, Couratier P, Dangoumau A, Bellance R, Desnuelle C, Viader F, Pautot V, Millecamps S, Bakkouche S, Salachas F, Andres CR, Meininger V, Camu W.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):432-437. doi: 10.1080/21678421.2018.1440406. Epub 2018 Mar 1.

PMID:
29493298
23.

The Metabolic Disturbances of Motoneurons Exposed to Glutamate.

Madji Hounoum B, Blasco H, Coque E, Vourc'h P, Emond P, Corcia P, Andres CR, Raoul C, Mavel S.

Mol Neurobiol. 2018 Oct;55(10):7669-7676. doi: 10.1007/s12035-018-0945-8. Epub 2018 Feb 12.

PMID:
29435916
24.

How Can a Ketogenic Diet Improve Motor Function?

Veyrat-Durebex C, Reynier P, Procaccio V, Hergesheimer R, Corcia P, Andres CR, Blasco H.

Front Mol Neurosci. 2018 Jan 26;11:15. doi: 10.3389/fnmol.2018.00015. eCollection 2018. Review.

25.

Are Carpal Tunnel Syndrome and Regional Degenerative Osteoarthritis Linked? Results of a Case-Control Study.

Bacle G, Marteau E, Corcia P, Garaud P, Laulan J.

J Hand Surg Asian Pac Vol. 2018 Mar;23(1):41-46. doi: 10.1142/S2424835518500054.

PMID:
29409410
26.

Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration.

Maurel C, Dangoumau A, Marouillat S, Brulard C, Chami A, Hergesheimer R, Corcia P, Blasco H, Andres CR, Vourc'h P.

Mol Neurobiol. 2018 Aug;55(8):6480-6499. doi: 10.1007/s12035-017-0856-0. Epub 2018 Jan 10. Review.

PMID:
29322304
27.

Nerve Biopsy Is Still Useful in Some Inherited Neuropathies.

Duchesne M, Mathis S, Richard L, Magdelaine C, Corcia P, Nouioua S, Tazir M, Magy L, Vallat JM.

J Neuropathol Exp Neurol. 2018 Feb 1;77(2):88-99. doi: 10.1093/jnen/nlx111. Review.

PMID:
29300988
28.

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?

Moreau C, Danel V, Devedjian JC, Grolez G, Timmerman K, Laloux C, Petrault M, Gouel F, Jonneaux A, Dutheil M, Lachaud C, Lopes R, Kuchcinski G, Auger F, Kyheng M, Duhamel A, Pérez T, Pradat PF, Blasco H, Veyrat-Durebex C, Corcia P, Oeckl P, Otto M, Dupuis L, Garçon G, Defebvre L, Cabantchik ZI, Duce J, Bordet R, Devos D.

Antioxid Redox Signal. 2018 Sep 10;29(8):742-748. doi: 10.1089/ars.2017.7493. Epub 2018 Feb 8.

29.

Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS.

Blasco H, Veyrat-Durebex C, Bocca C, Patin F, Vourc'h P, Kouassi Nzoughet J, Lenaers G, Andres CR, Simard G, Corcia P, Reynier P.

Sci Rep. 2017 Dec 15;7(1):17652. doi: 10.1038/s41598-017-17389-9.

30.

Reconsidering the causality of TIA1 mutations in ALS.

van der Spek RA, van Rheenen W, Pulit SL, Kenna KP, Ticozzi N, Kooyman M, Mclaughlin RL, Moisse M, van Eijk KR, van Vugt JJFA, Iacoangeli A, Andersen P, Nazli Basak A, Blair I, de Carvalho M, Chio A, Corcia P, Couratier P, Drory VE, Glass JD, Hardiman O, Mora JS, Morrison KE, Mitne-Neto M, Robberecht W, Shaw PJ, Panadés MP, van Damme P, Silani V, Gotkine M, Weber M, van Es MA, Landers JE, Al-Chalabi A, van den Berg LH, Veldink JH; PROJECT MINE ALS SEQUENCING CONSORTIUM.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):1-3. doi: 10.1080/21678421.2017.1413118. Epub 2017 Dec 13. No abstract available. Erratum in: Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):161.

31.

Are the clinical classifications for psychogenic nonepileptic seizures reliable?

Duwicquet C, de Toffol B, Corcia P, Bonnin M, El-Hage W, Biberon J.

Epilepsy Behav. 2017 Dec;77:53-57. doi: 10.1016/j.yebeh.2017.09.013. Epub 2017 Nov 5.

PMID:
29111503
32.

The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?

Bruno C, Patin F, Bocca C, Nadal-Desbarats L, Bonnier F, Reynier P, Emond P, Vourc'h P, Joseph-Delafont K, Corcia P, Andres CR, Blasco H.

J Pharm Biomed Anal. 2018 Jan 30;148:273-279. doi: 10.1016/j.jpba.2017.10.013. Epub 2017 Oct 18.

PMID:
29059617
33.

July 2017 ENCALS statement on edaravone.

Al-Chalabi A, Andersen PM, Chandran S, Chio A, Corcia P, Couratier P, Danielsson O, de Carvalho M, Desnuelle C, Grehl T, Grosskreutz J, Holmøy T, Ingre C, Karlsborg M, Kleveland G, Koch JC, Koritnik B, KuzmaKozakiewicz M, Laaksovirta H, Ludolph A, McDermott C, Meyer T, Mitre Ropero B, Mora Pardina J, Nygren I, Petri S, Povedano Panades M, Salachas F, Shaw P, Silani V, Staaf G, Svenstrup K, Talbot K, Tysnes OB, Van Damme P, van der Kooi A, Weber M, Weydt P, Wolf J, Hardiman O, van den Berg LH.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):471-474. doi: 10.1080/21678421.2017.1369125. Epub 2017 Oct 4. Review. No abstract available.

34.

Low IDL-B and high LDL-1 subfraction levels in serum of ALS patients.

Delaye JB, Patin F, Piver E, Bruno C, Vasse M, Vourc'h P, Andres CR, Corcia P, Blasco H.

J Neurol Sci. 2017 Sep 15;380:124-127. doi: 10.1016/j.jns.2017.07.019. Epub 2017 Jul 18.

PMID:
28870551
35.

C-reactive protein: A promising biomarker in ALS?

Corcia P, Blasco H, Beltran S, Andres C, Vourc'h P, Couratier P.

Rev Neurol (Paris). 2018 Mar;174(3):104-105. doi: 10.1016/j.neurol.2017.07.001. Epub 2017 Aug 7. No abstract available.

PMID:
28797688
36.

Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.

Hamidou B, Marin B, Lautrette G, Nicol M, Camu W, Corcia P, Arnes-Bes MC, Tranchant C, Clavelou P, Hannequin D, Maurice G, Beauvais K, Antoine JC, Danel-Brunaud V, Viader F, Preux PM, Couratier P.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Nov;18(7-8):519-527. doi: 10.1080/21678421.2017.1353098. Epub 2017 Aug 1.

PMID:
28762856
37.

Mutation in the RRM2 domain of TDP-43 in Amyotrophic Lateral Sclerosis with rapid progression associated with ubiquitin positive aggregates in cultured motor neurons.

Maurel C, Madji-Hounoum B, Thepault RA, Marouillat S, Brulard C, Danel-Brunaud V, Camdessanche JP, Blasco H, Corcia P, Andres CR, Vourc'h P.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):149-151. doi: 10.1080/21678421.2017.1349152. Epub 2017 Jul 13.

PMID:
28705014
38.

Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis.

Henriques A, Huebecker M, Blasco H, Keime C, Andres CR, Corcia P, Priestman DA, Platt FM, Spedding M, Loeffler JP.

Sci Rep. 2017 Jul 12;7(1):5235. doi: 10.1038/s41598-017-05313-0.

39.

Motor neuron disease of very long disease duration or Charcot-Marie-Tooth disease? A novel phenotype related to the SOD1 p.E22G variant.

Querin G, Corcia P, Lenglet T, Stojkovic T, Leguern E, Cazeneuve C, Pradat PF.

Rev Neurol (Paris). 2017 Dec;173(10):671-673. doi: 10.1016/j.neurol.2017.05.008. Epub 2017 Jun 1. No abstract available.

PMID:
28579206
40.

An UPLC-MSMS method to measure plasma homocysteine concentration.

Vayne C, Deroche L, Drillaud N, Patin F, Bruno C, Maillot F, Labarthe F, Corcia P, Benz-de Bretagne I, Andres CR, Emond P, Blasco H.

Ann Biol Clin (Paris). 2017 Jun 1;75(3):334-338. doi: 10.1684/abc.2017.1248.

PMID:
28540856
41.

ALS and frontotemporal dementia belong to a common disease spectrum.

Couratier P, Corcia P, Lautrette G, Nicol M, Marin B.

Rev Neurol (Paris). 2017 May;173(5):273-279. doi: 10.1016/j.neurol.2017.04.001. Epub 2017 Apr 24. Review.

PMID:
28449882
42.

Genetics of amyotrophic lateral sclerosis.

Corcia P, Couratier P, Blasco H, Andres CR, Beltran S, Meininger V, Vourc'h P.

Rev Neurol (Paris). 2017 May;173(5):254-262. doi: 10.1016/j.neurol.2017.03.030. Epub 2017 Apr 25. Review.

PMID:
28449881
43.

A decrease in blood cholesterol after gastrostomy could impact survival in ALS.

Blasco H, Patin F, Molinier S, Vourc'h P, Le Tilly O, Bakkouche S, Andres CR, Meininger V, Couratier P, Corcia P.

Eur J Clin Nutr. 2017 Sep;71(9):1133-1135. doi: 10.1038/ejcn.2017.54. Epub 2017 Apr 19.

PMID:
28422121
44.

Current view and perspectives in amyotrophic lateral sclerosis.

Mathis S, Couratier P, Julian A, Corcia P, Le Masson G.

Neural Regen Res. 2017 Feb;12(2):181-184. doi: 10.4103/1673-5374.200794. Review.

45.

SOD1 mutation can mask C9orf72 abnormal expansion.

Corcia P, Blasco H, Besson G, Camdessanché JP, Pautot V, Beltran S, Couratier P, Andres C, Camu W, Vourc'h P.

Eur J Neurol. 2017 Apr;24(4):e24. doi: 10.1111/ene.13257. No abstract available.

PMID:
28322003
46.

Liver X Receptor Genes Variants Modulate ALS Phenotype.

Mouzat K, Molinari N, Kantar J, Polge A, Corcia P, Couratier P, Clavelou P, Juntas-Morales R, Pageot N, Lobaccaro J-A, Raoul C, Lumbroso S, Camu W.

Mol Neurobiol. 2018 Mar;55(3):1959-1965. doi: 10.1007/s12035-017-0453-2. Epub 2017 Feb 27.

PMID:
28244008
47.

Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis.

Ohta Y, Soucy G, Phaneuf D, Audet JN, Gros-Louis F, Rouleau GA, Blasco H, Corcia P, Andersen PM, Nordin F, Yamashita T, Abe K, Julien JP.

Hum Mol Genet. 2016 Nov 1;25(21):4771-4786. doi: 10.1093/hmg/ddw304.

48.

Wildtype motoneurons, ALS-Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttling.

Madji Hounoum B, Mavel S, Coque E, Patin F, Vourc'h P, Marouillat S, Nadal-Desbarats L, Emond P, Corcia P, Andres CR, Raoul C, Blasco H.

Glia. 2017 Apr;65(4):592-605. doi: 10.1002/glia.23114. Epub 2017 Jan 31.

PMID:
28139855
49.

A novel mutation of the C-terminal amino acid of FUS (Y526C) strengthens FUS gene as the most frequent genetic factor in aggressive juvenile ALS.

Corcia P, Danel V, Lacour A, Beltran S, Andres C, Couratier P, Blasco H, Vourc'h P.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):298-301. doi: 10.1080/21678421.2016.1265564. Epub 2017 Jan 5.

PMID:
28054830
50.

Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome.

Mathis S, Magy L, Corcia P, Ghorab K, Richard L, Ciron J, Duchesne M, Vallat JM.

Case Rep Neurol Med. 2016;2016:6108234. doi: 10.1155/2016/6108234. Epub 2016 Dec 1.

Supplemental Content

Loading ...
Support Center